Press Releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Mar 3, 2025
Acquisition to expand Interventional Cardiology Therapies offerings with ultrasound-based renal denervation therapy for treatment of hypertension MARLBOROUGH, Mass., March 3, 2025 /PRNewswire/ --...
-
Feb 17, 2025Il catetere di ablazione FARAWAVE™ NAV e il modulo FARAVIEW™, combinati con il sistema di mappatura di Boston Scientific, consentono una cartografia durante l'ablazione per elettroporazione.
MILANO, Italia, 17 febbraio 2025 – Boston Scientific Corporation (NYSE: BSX) ha annunciato oggi di aver ottenuto il marchio CE per il catetere di ablazione FARAWAVE™ NAV, una tecnologia di...
-
Feb 17, 2025El catéter de ablación FARAWAVE™ NAV y el software FARAVIEW™, combinados con el sistema de mapeo de Boston Scientific, permiten una cartografía durante la ablación por electroporación.
MADRID, España 17 de febrero de 2025 – Boston Scientific Corporation (NYSE: BSX) anunció hoy que ha obtenido el marcado CE para el catéter de ablación FARAWAVE™ NAV, una tecnología de...
-
Feb 17, 2025FARAWAVE™ NAV Ablationskatheter und FARAVIEW™ Software in Kombination mit dem Boston Scientific Mapping-System ermöglichen Mapping für die Pulsed Field Ablation
DÜSSELDORF, Deutschland - 17. Februar 2025 – Die Boston Scientific Corporation (NYSE: BSX) hat die CE-Kennzeichnung für den navigationsfähigen FARAWAVE™ NAV-Ablationskatheter zur Behandlung...
-
Feb 17, 2025FARAWAVE™ NAV Ablation Catheter and FARAVIEW™ Software combine with Boston Scientific mapping system to provide mapping during pulsed field ablation
LONDON, United Kingdom, 17 February, 2025 – Boston Scientific Corporation (NYSE: BSX) today announced it has received CE mark for the navigation-enabled FARAWAVE™ NAV Ablation Catheter for the...